Related Experiment Videos
Haemochromatosis gene mutations and risk of coronary artery disease
E Battiloro1, D Ombres, E Pascale
1Cattedra di Patologia Clinica, Dipartimento di Medicina Sperimentale e Patologia, Università di Roma La Sapienza, Rome, Italy.
Insights
Genetic mutations in the haemochromatosis gene (HFE), C282Y and H63D, were investigated for their link to coronary artery disease. These HFE gene variants were not found to be associated with coronary atherosclerosis or its complications.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Iron Metabolism
Background:
- Mutations in the haemochromatosis gene (HFE), specifically C282Y and H63D, are known to cause tissue iron accumulation.
- The potential influence of these iron-related genetic variants on the risk of coronary atherosclerosis has not been extensively studied.
Purpose of the Study:
- To investigate the association between HFE gene mutations (C282Y and H63D) and the presence and severity of coronary atherosclerosis.
- To determine if HFE variants are significant genetic markers for coronary artery disease (CAD) and myocardial infarction (MI).
Main Methods:
- A case-control study was conducted involving 174 patients with angiographically confirmed CAD and a history of MI.
- Prevalence of C282Y and H63D HFE mutations was compared between patients and 187 healthy controls and 142 blood donors.
- Severity of coronary atherosclerosis was assessed in patients with documented CAD.
Main Results:
- The prevalence of C282Y and H63D mutations was similar in patients with coronary atherosclerosis and control groups.
- No significant association was found between HFE variants and the presence of coronary atherosclerosis.
- HFE mutations were unrelated to the severity of coronary atherosclerosis in the studied population.
Conclusions:
- The study found no evidence to support an association between HFE gene mutations and coronary atherosclerosis or its ischemic complications.
- HFE mutations (C282Y and H63D) are unlikely to be reliable genetic markers for predicting coronary risk.
- Further research may be needed to explore other genetic factors influencing coronary artery disease.
Abstract:
The identification of mutations in the haemochromatosis gene (HFE) (C282Y and H63D) provides the unique opportunity to test whether genetic variants that are associated with tissue iron accumulation may influence the risk of coronary atherosclerosis. To this aim the prevalence of C282Y and H63D mutations was determined in 174 patients with angiographically documented CAD (>50% stenosis) and history of MI, 187 healthy free-living individuals and 142 blood donors. C282Y and H63D mutations were not found to be more frequent in coronary patients as compared to controls. Moreover, these HFE variants were unrelated to the severity of coronary atherosclerosis. These findings did not provide evidence of an association between HFE mutations and the presence of coronary atherosclerosis or its major ischaemic complications, thus indicating that HFE mutations are poor genetic markers of coronary risk.